Login to Your Account



Minerva, Cymbay, Dance file to catch IPO wave

By Michael Fitzhugh
Staff Writer

Thursday, April 10, 2014
Three clinical-stage companies, Minerva Neurosciences Inc., Cymabay Therapeutics Inc. and Dance Biopharm Inc. filed for initial public offerings (IPO) on Nasdaq in hopes of harnessing millions of dollars from enthusiastic investors and riding momentum from a first quarter in which 28 biotech IPOs raised $2.2 billion.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription